Global Prostate Cancer Treatment Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 152456
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 117
  • list Pharmaceuticals and Healthcare

Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.

Scope of the Report:

The worldwide market for Prostate Cancer Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Prostate Cancer Treatment Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Tolmar

Astellas Pharma

AstraZeneca

Ferring Pharmaceuticals

Johnson & Johnson

Abbott

Sanofi

Ipsen

Novartis

Bayer

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Enzalutamid

Abiraterone

Leuprolide

Goserelin

Triptorelin

Histrelin

Degarelix

Sipuleucel-T

Docetaxel

Cabazitaxel

Market Segment by Applications, can be divided into

Hospital

Research Institution

Clinic

Drugstore

There are 15 Chapters to deeply display the global Prostate Cancer Treatment Drugs market.

Chapter 1, to describe Prostate Cancer Treatment Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Prostate Cancer Treatment Drugs, with sales, revenue, and price of Prostate Cancer Treatment Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Prostate Cancer Treatment Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Prostate Cancer Treatment Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Prostate Cancer Treatment Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Prostate Cancer Treatment Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Enzalutamid

1.2.2 Abiraterone

1.2.3 Leuprolide

1.2.4 Goserelin

1.2.5 Triptorelin

1.2.6 Histrelin

1.2.7 Degarelix

1.2.8 Sipuleucel-T

1.2.9 Docetaxel

1.2.10 Cabazitaxel

1.3 Market Analysis by Applications

1.3.1 Hospital

1.3.2 Research Institution

1.3.3 Clinic

1.3.4 Drugstore

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Tolmar

2.1.1 Business Overview

2.1.2 Prostate Cancer Treatment Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Tolmar Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Astellas Pharma

2.2.1 Business Overview

2.2.2 Prostate Cancer Treatment Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Astellas Pharma Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 AstraZeneca

2.3.1 Business Overview

2.3.2 Prostate Cancer Treatment Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 AstraZeneca Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Ferring Pharmaceuticals

2.4.1 Business Overview

2.4.2 Prostate Cancer Treatment Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Johnson & Johnson

2.5.1 Business Overview

2.5.2 Prostate Cancer Treatment Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Johnson & Johnson Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Abbott

2.6.1 Business Overview

2.6.2 Prostate Cancer Treatment Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Abbott Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Sanofi

2.7.1 Business Overview

2.7.2 Prostate Cancer Treatment Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Sanofi Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Ipsen

2.8.1 Business Overview

2.8.2 Prostate Cancer Treatment Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Ipsen Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Novartis

2.9.1 Business Overview

2.9.2 Prostate Cancer Treatment Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Novartis Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Bayer

2.10.1 Business Overview

2.10.2 Prostate Cancer Treatment Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Bayer Prostate Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Prostate Cancer Treatment Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Prostate Cancer Treatment Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Prostate Cancer Treatment Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Prostate Cancer Treatment Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Prostate Cancer Treatment Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Prostate Cancer Treatment Drugs Market Analysis by Regions

4.1 Global Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Prostate Cancer Treatment Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Prostate Cancer Treatment Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

4.5 South America Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

5 North America Prostate Cancer Treatment Drugs by Countries

5.1 North America Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Prostate Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Prostate Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

6 Europe Prostate Cancer Treatment Drugs by Countries

6.1 Europe Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Prostate Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Prostate Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

6.3 UK Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

6.4 France Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Prostate Cancer Treatment Drugs by Countries

7.1 Asia-Pacific Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Prostate Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Prostate Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

7.5 India Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

8 South America Prostate Cancer Treatment Drugs by Countries

8.1 South America Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Prostate Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Prostate Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Prostate Cancer Treatment Drugs by Countries

9.1 Middle East and Africa Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Prostate Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Prostate Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Prostate Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

10 Global Prostate Cancer Treatment Drugs Market Segment by Type

10.1 Global Prostate Cancer Treatment Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Prostate Cancer Treatment Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Prostate Cancer Treatment Drugs Revenue and Market Share by Type (2013-2018)

10.2 Enzalutamid Sales Growth and Price

10.2.1 Global Enzalutamid Sales Growth (2013-2018)

10.2.2 Global Enzalutamid Price (2013-2018)

10.3 Abiraterone Sales Growth and Price

10.3.1 Global Abiraterone Sales Growth (2013-2018)

10.3.2 Global Abiraterone Price (2013-2018)

10.4 Leuprolide Sales Growth and Price

10.4.1 Global Leuprolide Sales Growth (2013-2018)

10.4.2 Global Leuprolide Price (2013-2018)

10.5 Goserelin Sales Growth and Price

10.5.1 Global Goserelin Sales Growth (2013-2018)

10.5.2 Global Goserelin Price (2013-2018)

10.6 Triptorelin Sales Growth and Price

10.6.1 Global Triptorelin Sales Growth (2013-2018)

10.6.2 Global Triptorelin Price (2013-2018)

10.7 Histrelin Sales Growth and Price

10.7.1 Global Histrelin Sales Growth (2013-2018)

10.7.2 Global Histrelin Price (2013-2018)

10.8 Degarelix Sales Growth and Price

10.8.1 Global Degarelix Sales Growth (2013-2018)

10.8.2 Global Degarelix Price (2013-2018)

10.9 Sipuleucel-T Sales Growth and Price

10.9.1 Global Sipuleucel-T Sales Growth (2013-2018)

10.9.2 Global Sipuleucel-T Price (2013-2018)

10.10 Docetaxel Sales Growth and Price

10.10.1 Global Docetaxel Sales Growth (2013-2018)

10.10.2 Global Docetaxel Price (2013-2018)

10.11 Cabazitaxel Sales Growth and Price

10.11.1 Global Cabazitaxel Sales Growth (2013-2018)

10.11.2 Global Cabazitaxel Price (2013-2018)

11 Global Prostate Cancer Treatment Drugs Market Segment by Application

11.1 Global Prostate Cancer Treatment Drugs Sales Market Share by Application (2013-2018)

11.2 Hospital Sales Growth (2013-2018)

11.3 Research Institution Sales Growth (2013-2018)

11.4 Clinic Sales Growth (2013-2018)

11.5 Drugstore Sales Growth (2013-2018)

12 Prostate Cancer Treatment Drugs Market Forecast (2018-2023)

12.1 Global Prostate Cancer Treatment Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Prostate Cancer Treatment Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Prostate Cancer Treatment Drugs Market Forecast (2018-2023)

12.2.2 Europe Prostate Cancer Treatment Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Prostate Cancer Treatment Drugs Market Forecast (2018-2023)

12.2.4 South America Prostate Cancer Treatment Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Prostate Cancer Treatment Drugs Market Forecast (2018-2023)

12.3 Prostate Cancer Treatment Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Prostate Cancer Treatment Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Prostate Cancer Treatment Drugs Market Share Forecast by Type (2018-2023)

12.4 Prostate Cancer Treatment Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Prostate Cancer Treatment Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Prostate Cancer Treatment Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Prostate Cancer Treatment Drugs Picture

Table Product Specifications of Prostate Cancer Treatment Drugs

Figure Global Sales Market Share of Prostate Cancer Treatment

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery